Australia to ban copycat versions of weight loss drugs like Ozempic [Seeking Alpha]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Seeking Alpha
adverse events linked to the so-called compounded versions, which are made without regulatory oversight, the country's health minister, Mark Butler, said Wednesday. Demand for compounded alternatives of Novo's ( OTCPK:NONOF ) Ozempic and Lilly's ( LLY ) Mounjaro has taken off amid supply constraints for branded versions, which are indicated for diabetes but are increasingly used off-label for weight loss. Compounded drugs are personalized, cheaper versions of branded drugs based on the same active ingredient, also known as GLP-1 receptor agonists. However, they are not clinically tested by regulators for safety, quality, or efficacy. "To keep Australians safe, new regulations will remove (GLP-1 receptor agonists), such as those being misrepresented and sold as replica Ozempic or Mounjaro, from the pharmacy compounding exemptions," Butler said. The ban will take effect on October 1, 2024, to give patients enough time to consult their doctors and seek alternatives. Novo ( NVO
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly unveils new manufacturing plant for GLP-1 pens [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pre-diabetes rates increase amidst a renaissance for type 2 diabetes research [Yahoo! Finance]Yahoo! Finance
- Biologics Market to Surpass USD 1125.55 Billion by 2031 | SkyQuest [Yahoo! Finance]Yahoo! Finance
- Eli Lilly doubles investment to $2 billion in Concord pharma facility ahead of opening [Yahoo! Finance]Yahoo! Finance
- Aktis Oncology Expands its Board of Directors with Appointment of Nuclear Medicine Expert Ken Herrmann, MD, MBA [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 6/14/24 - Form 144
- 6/11/24 - Form 4
- 6/10/24 - Form 4
- LLY's page on the SEC website